These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 326401)

  • 1. Comparative trial of adriamycin and 5-fluorouracil in advanced prostatic cancer--progress report.
    DeWys WD; Bauer M; Colsky J; Cooper RA; Creech R; Carbone PP
    Cancer Treat Rep; 1977; 61(2):325-8. PubMed ID: 326401
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of adriamycin (NSC-123127) and 5-fluorouracil (NSC-19893) in advanced prostatic cancer.
    DeWys WD
    Cancer Chemother Rep; 1975; 59(1):215-7. PubMed ID: 1093668
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparative clinical trial of adriamycin and 5-fluorouracil in advanced prostatic cancer: prognostic factors and response.
    DeWys WD; Begg CB; Brodovsky H; Creech R; Khandekar J
    Prostate; 1983; 4(1):1-11. PubMed ID: 6340081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II trial of 5-fluorouracil, adriamycin, and mitomycin C in advanced colorectal cancer.
    Haller DG; Woolley PV; Macdonald JS; Smith LF; Schein PS
    Cancer Treat Rep; 1978 Apr; 62(4):563-5. PubMed ID: 350394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic manipulation of Nb rat prostatic adenocarcinomas: chemotherapeutic evaluation of autonomous tumors.
    Drago JR; Goldman LB; Maurer RE; Gershwin ME; Eckels DD
    Invest Urol; 1979 Nov; 17(3):203-6. PubMed ID: 500317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cooperative clinical trials in prostate cancer.
    Murphy GP; Slack NH
    Prog Clin Biol Res; 1981; 75B():341-6. PubMed ID: 7323102
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemotherapy of advanced carcinoma of the prostate with 5-fluorouracil, cyclophosphamide and adriamycin.
    Merrin C; Etra W; Wajsman Z; Baumgartner G; Murphy G
    J Urol; 1976 Jan; 115(1):86-8. PubMed ID: 1107604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-fluorouracil, methyl-CCNU, adriamycin, and mitomycin C in the treatment of advanced gastric cancer.
    Bunn PA; Nugent JL; Ihde DC; Cohen MH; Eddy JL; Minna JD
    Cancer Treat Rep; 1978 Sep; 62(9):1287-93. PubMed ID: 356983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adriamycin (NSC-123127) versus 5-fluorouracil (NSC-19893) and cyclophosphamide (NSC-26271) in the treatment of metastatic prostate cancer.
    Eagan RT; Hahn RG; Myers RP
    Cancer Treat Rep; 1976 Jan; 60(1):115-7. PubMed ID: 1000515
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of metastasizing prostatic carcinoma with DMF. Presentation of a prospective study].
    Burk K; Gropp C; Rodeck G
    Urologe A; 1983 Sep; 22 Suppl():347-9. PubMed ID: 6415885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate adenocarcinoma model: Nb rat chemotherapy.
    Drago JR; Gershwin ME; Goldman LB
    Surg Forum; 1979; 30():558-9. PubMed ID: 538694
    [No Abstract]   [Full Text] [Related]  

  • 12. Further experience with chemotherapy in the Dunning prostatic adenocarcinoma.
    Block NL; Camuzzi F; Stover B; Claflin A; Troner M; Politano VA
    Trans Am Assoc Genitourin Surg; 1978; 70():57-9. PubMed ID: 753023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of adriamycin (NSC-123127) and the combination of 5-fluorouracil (NSC-19893) and cyclophosphamide (NSC-26271) in advanced prostatic cancer: a preliminary report.
    Eagan RT; Utz DC; Myers RP; Furlow WL
    Cancer Chemother Rep; 1975; 59(1):203-7. PubMed ID: 1093666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial of 5-fluorouracil (NSC-19893), adriamycin (NSC-123127), and methotrexate (NSC-740) in lung adenocarcinoma.
    Lowitz BB
    Cancer Treat Rep; 1976 May; 60(5):623-4. PubMed ID: 991153
    [No Abstract]   [Full Text] [Related]  

  • 15. Combination chemotherapy of advanced endometrial adenocarcinoma with adriamycin, cyclophosphamide, 5-fluorouracil, and medroxyprogesterone acetate.
    Bruckner HW; Deppe G
    Obstet Gynecol; 1977 Jul; 50(1 Suppl):10s-12s. PubMed ID: 876531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of chemotherapeutic responsiveness in Nb rat prostate cancer model. 5-fluorouracil, methotrexate, cyclophosphamide, and adriamycin.
    Drago JR; Goldman L; Gershwin ME
    Invest Urol; 1980 Jul; 18(1):80-1. PubMed ID: 7410017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fluorouracil, mitomycin-C and adriamycin in the treatment of metastasizing gastrointestinal adenocarcinomas].
    Späti B; Jungi WF; Mayr AC; Hammer B; Senn HJ
    Schweiz Med Wochenschr; 1980 Jul; 110(27-28):1076-8. PubMed ID: 7423154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The randomized clinical trial: a prerequisite for rational therapy.
    Staquet M
    Eur Urol; 1976; 2(6):265-70. PubMed ID: 829222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxorubicin, mitomycin, and 5-FU (DMF) in the treatment of hormone-resistant stage D prostate cancer: a preliminary report.
    Logothetis CJ; von Eschenbach AC; Samuels ML; Trindade A; Johnson DE
    Cancer Treat Rep; 1982 Jan; 66(1):57-63. PubMed ID: 7053267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy of advanced prostatic cancer today.
    Murphy GP; Merrin CE
    Prog Clin Biol Res; 1976; 6():285-99. PubMed ID: 139614
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.